𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis

✍ Scribed by Antoni Rimola; Miquel Navasa; Vicente Arroyo

Book ID
116150056
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
972 KB
Volume
22
Category
Article
ISSN
0732-8893

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cefotaxime in the treatment of spontaneo
Cefotaxime in the treatment of spontaneous bacterial peritonitis
✍ X Xiol; J Ariza πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views

In a recently published report, Rimola et al. compared Gudiol F. Aztreonam vs cefotaxime in the treatment of gramtwo different dosages of cefotaxime (CTX) in the treatnegative spontaneous bacterial peritonitis. HEPATOLOGY 1991;14: 91-98. ment of spontaneous bacterial peritonitis (SBP). 1 They 3. Cra

Spontaneous bacterial peritonitis in cir
Spontaneous bacterial peritonitis in cirrhosis: Predictive factors of infection resolution and survival in patients treated with cefotaxime
✍ Claudio Toledo; Joan-Manuel SalmerΓ³n; Dr. Antoni Rimola; Miquel Navasa; Vicente πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 773 KB

Cefotaxime is the most commonly used antibiotic for initial therapy of spontaneous bacterial peritonitis in cirrhosis. However, since the introduction of cefotaxime no study has been performed to investigate factors influencing prognosis in cirrhotic patients with this type of infection. In this stu